Related Experiment Video
Updated: Sep 18, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Beyond weight loss: GLP-1 emerges as a disease-modifying signal in osteoarthritis
1Department of Rheumatology, Sorbonne Université, Inserm CRSA, AP-HP Hôpital Saint-Antoine, Paris, France.
No abstract available in PubMed .
More Related Videos
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Dipeptidyl Peptidase 4 Inhibitors
GPCRs Regulate Adenylyl Cylase Activity
Osteoclasts in Bone Remodeling